Audrey Jia, Managing Director of Data Revive LLC (a Validant company) will be delivering a Keynote Speech about “Regulatory Challenge from R&D to Marketing for Biological Drugs” during China BioMed Innovation and Investment Conference (CBIIC), which is an annual grand conference to promote the communication between pharmaceutical and investment industry.
By the end of 2019, CBIIC has attracted over 10,000 participants, 2,100 domestic and foreign pharmaceutical enterprises and 1,500 investment institutions, and 33 new drugs made global first clinical trial data release, 450 innovative projects at home and abroad made roadshows in this events, including 80 international projects. CBIIC received extensive attention and was praised as the “most popular cooperation platform for pharmaceutical innovation and investment in Asian-Pacific region”.
Checkout more from: http://cbiic.phirda.com/portal/index/about.html
DataRevive is a leading Regulatory Affairs consulting firm helping pharmaceutical and biotech companies with their regulatory filing of US IND, BLA, and NDA during drug development. DataRevive specializes in both small molecule and biologic product regulatory affairs. They have expertise in CMC (chemistry, manufacturing, controls), nonclinical, clinical pharmacology and clinical areas. Their lead consultants have worked in FDA or industry for more than 18 years with extensive experience in drug discovery and development. For further information, please visit http://www.data-revive.com.
With Validant, I have the opportunity to work with pharmaceutical companies worldwide that are working to positively impact patient health. My skills from 37 years in industry in Quality System Implementation and Quality Remediation are directly applicable to help our clients.
John M. | Validant Managing Partner since 2016
Validant offers win-win solutions for clients and consultants, continually building and maintaining lasting relationships. Their experts in business development and recruiting ensure that subject matter expertise and skill set is matched for the client and the best consultants are placed on the project.
Janet W. | Validant Consultant since 2013
In the spring of 2015, my firm had a significant FDA audit with serious findings concerning sterility assurance and data integrity. We had utilized Validant for a previous engagement successfully. Before the audit concluded, I was already in contact with the Validant team for assistance. I was very impressed by how quickly they orchestrated data integrity audits at all of our 20+ other sites. We then turned to them for assistance with our third-party oversight of our manufacturing operation and quality control laboratories.